People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cambium Biomaterials, Inc. | — | Other Technology | Series C | $119.7M | $580.1M | 2025 |
Nic Madren at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nic Madren on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Francisco Gimenez | 1 | 7 |
| Simon Waddington | 1 | 2 |
| Brett Schneider | 1 | 1 |
| Tim Gardner | 1 | 1 |
| Stephan Herrera | 1 | 1 |
| James Griffin | 1 | 1 |
| Eliot Pence | 1 | 1 |
| ANDREW GUENTHNER | 1 | 1 |
| Christopher Pederson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.